Fundz

Zai Lab Limited reported raising $250 Million in an initial SEC Form D filing, from an offering of $250 Million

PUBLIC · ZLABOct 23, 2026

Amount Raised

$250 Million

$250 Million sold, per SEC Form D (first sale Oct 27, 2026)
$250 Million per company press release (Oct 23, 2026)

Round Type

Post-IPO Equity

ShanghaiBiotechnologyHealth CareBiopharma

Description

Zai Lab Limited has announced a $250 million private placement. The company will issue 11,340,000 American Depositary Shares at a price of $22.04 per share. This private investment in public equity (PIPE) will provide substantial capital for its innovative biopharma initiatives. The funding underscores investor confidence in Zai Lab's growth potential.

Quick answer

Zai Lab Limited raised $250 Million in a Post-IPO Equity round, dated October 23, 2026. Zai Lab Limited is based in Shanghai, China.

How much did Zai Lab Limited raise?
Zai Lab Limited raised $250 Million in a Post-IPO Equity round on October 23, 2026.
What does Zai Lab Limited do?
Zai Lab Limited is an innovative, research-based, commercial-stage biopharmaceutical company based in China and the United States.
Where is Zai Lab Limited based and how big is it?
Zai Lab Limited is based in Shanghai, China.

Source: Fundz verified event record.

Who else raised in Biopharma and Biotechnology around the same time

Companies in the same sectors as Zai Lab Limited that raised within 45 days of this round, from Fundz verified event records.

  • Vivani Medical, Inc. raised $5.1M (Post-IPO Equity) on November 16, 2026.
  • BioVie raised $4.7M (Post-IPO Equity) on November 6, 2026.
  • Quanta Therapeutics raised an undisclosed amount (Series D) on October 24, 2026.
  • Disc raised $422M (Post-IPO Equity) on October 20, 2026.
  • GenSight Biologics raised $1.1M (Post-IPO Equity) on October 16, 2026.
  • Acta Pharmaceuticals raised $24M (Seed) on October 15, 2026.

Who to call at Zai Lab Limited, and when

A new round usually means Zai Lab Limited is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Zai Lab Limited raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Zai Lab Limited, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Zai Lab Limited. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Zai Lab Limited

Location

Shanghai, China

About

Zai Lab Limited is an innovative, research-based, commercial-stage biopharmaceutical company based in China and the United States. The company focuses on discovering, developing, and commercializing innovative products that address medical conditions with significant unmet needs in oncology, immunology, neuroscience, and infectious disease. Zai Lab aims to leverage its competencies and resources to positively impact human health in China and worldwide.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Zai Lab Limited raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Zai Lab Limited's next move

See what Strategic adds

Zai Lab Limited raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.